InChI=1S/C30H41N5O6S/c1- 8- 21- 15- 24(36) 41- 19(5) 29(39) 35(7) 25(17(2) 3) 30(40) 34(6) 23(14- 20- 12- 10- 9- 11- 13- 20) 27(38) 31- 18(4) 28- 33- 22(16- 42- 28) 26(37) 32- 21/h9- 13,16- 19,21,23,25H,8,14- 15H2,1- 7H3,(H,31,38) (H,32,37) /t18- ,19- ,21- ,23- ,25- /m0/s1 |
HTERYHQTEBIQTA-USLAZGEGSA-N |
CC[C@H] 1CC(=O) O[C@@H] (C) C(=O) N(C) [C@@H] (C(C) C) C(=O) N(C) [C@@H] (Cc2ccccc2) C(=O) N[C@@H] (C) c2nc(cs2) C(=O) N1 |
|
Lyngbya confervoides
(NCBI:txid207921)
|
See:
PubMed
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
(2S,5S,8S,11S,15S)- 5- benzyl- 15- ethyl- 2,6,9,11- tetramethyl- 8- (propan- 2- yl)- 12- oxa- 20- thia- 3,6,9,16,21- pentaazabicyclo[16.2.1]henicosa- 1(21),18- diene- 4,7,10,13,17- pentone
|
(4S,8S,11S,14S,17S)- 14- benzyl- 4- ethyl- 8,10,13,17- tetramethyl- 11- propan- 2- yl- 7- oxa- 19- thia- 3,10,13,16,21- pentazabicyclo[16.2.1]henicosa- 1(20),18(21)- diene- 2,6,9,12,15- pentone
|
ChEBI
|
9101921
|
Reaxys Registry Number
|
Reaxys
|
11809060
|
PubMed citation
|
Europe PMC
|
|